A STUDY of 75,000 patients
between 1987 and 2006 by
researchers in Canada and
Germany has found that hormone
replacement therapy may be safer
when administered via low-dose
patches than in an oral form.
The British Medical Journal
published the research, which
found a 25-30% increased risk of
stroke among patients who used
oral HRT compared with those who
used none - but only in those who
took the tablets for over a year.
The results showed no increased
risk for those who were on low dose
HRT patches - but an 88% higher
risk for those on high dose patches.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jun 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.